Entocort Controlled Ileal Release (CIR) is local Budesonide (CorticoSteroid), which act topically at the site of inflammation itself with minimal systemic absorption, thus mild and minimal side effects.
Entocort CIR is the first-line treatment for acute mild-to-moderate ileocaecal Crohn’s disease.
Entocort CIR is the first-line and the only recommended treatment for Induction and Maintenance of clinical remission of Microscopic Colitis (MC).
Entocort 3 mg Capsules is preferably taken once daily in the morning time, usually 3 capsules (3x1) for 8 weeks, then taper the dose to 2 capsules (2x1) for two weeks, then, 1 Capsule for two weeks .
